» Articles » PMID: 31441162

Monitoring of Diffusion Properties and Transverse Relaxation Time of Mouse Ischaemic Muscle After Administration of Human Mesenchymal Stromal Cells Derived from Adipose Tissue

Overview
Journal Cell Prolif
Date 2019 Aug 24
PMID 31441162
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Application of non-invasive imaging methods plays an important role in the assessment of cellular therapy effects in peripheral artery disease. The purpose of this work was to evaluate the kinetics of MRI-derived parameters characterizing ischaemic hindlimb muscle after administration of human mesenchymal stromal cells derived from adipose tissue (hADSC) in mice.

Materials And Methods: MRI experiments were performed on a 9.4T Bruker system. The measurement protocol included transverse relaxation time mapping and diffusion tensor imaging. The monitoring period encompassed 14 days after femoral artery ligation and subsequent cell administration. The effect of hADSC transplantation was compared with the effect of normal human dermal fibroblasts (NHDFs) and phosphate-buffered saline injection.

Results: The most significant differences between the hADSC group and the remaining ones were observed around day 3 after ischaemia induction (increased transverse relaxation time in the hADSC group in comparison with the control group) and around day 7 (increased transverse relaxation time and decreased third eigenvalue of the diffusion tensor in the hADSC group in comparison with the control and NHDF groups) at the site of hADSC injection. Histologically, it was associated with increased macrophage infiltration at days 3-7 and with the presence of small regenerating fibres in the ischaemic tissue at day 7.

Conclusions: Our results underscore the important role of macrophages in mediating the therapeutic effects of hADSCs and confirm the huge potential of magnetic resonance imaging in monitoring of cellular therapy effects.

Citing Articles

In Vitro Cultures of Adipose-Derived Stem Cells: An Overview of Methods, Molecular Analyses, and Clinical Applications.

Jankowski M, Dompe C, Sibiak R, Wasiatycz G, Mozdziak P, Jaskowski J Cells. 2020; 9(8).

PMID: 32726947 PMC: 7463427. DOI: 10.3390/cells9081783.


Monitoring of diffusion properties and transverse relaxation time of mouse ischaemic muscle after administration of human mesenchymal stromal cells derived from adipose tissue.

Skorupa A, Ciszek M, Pilny E, Smolarczyk R, Jarosz-Biej M, Boguszewicz L Cell Prolif. 2019; 52(6):e12672.

PMID: 31441162 PMC: 6869084. DOI: 10.1111/cpr.12672.

References
1.
Li J, Ezzelarab M, Cooper D . Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation. 2012; 19(5):273-85. PMC: 3445044. DOI: 10.1111/xen.12000. View

2.
Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M . Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2008; 29(1):61-6. DOI: 10.1161/ATVBAHA.108.166496. View

3.
Laurila J, Laatikainen L, Castellone M, Trivedi P, Heikkila J, Hinkkanen A . Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy. 2009; 11(6):726-37. PMC: 2889035. DOI: 10.3109/14653240903067299. View

4.
Daldrup-Link H, Chan C, Lenkov O, Taghavigarmestani S, Nazekati T, Nejadnik H . Detection of Stem Cell Transplant Rejection with Ferumoxytol MR Imaging: Correlation of MR Imaging Findings with Those at Intravital Microscopy. Radiology. 2017; 284(2):495-507. PMC: 5548449. DOI: 10.1148/radiol.2017161139. View

5.
Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R . Critical limb ischemia: current challenges and future prospects. Vasc Health Risk Manag. 2018; 14:63-74. PMC: 5927064. DOI: 10.2147/VHRM.S125065. View